214 related articles for article (PubMed ID: 22532363)
1. [Prevention of uro-oncological diseases].
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
Urologe A; 2012 May; 51(5):727-36. PubMed ID: 22532363
[TBL] [Abstract][Full Text] [Related]
2. Prevention strategies for prostate cancer.
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C
Minerva Urol Nefrol; 2012 Dec; 64(4):225-31. PubMed ID: 23288209
[TBL] [Abstract][Full Text] [Related]
3. [Nutritional prevention of urological tumours].
Schmitz-Dräger BJ; Sahin S; Lümmen G; Bismarck E; Fischer C;
Aktuelle Urol; 2014 Jul; 45(4):281-5. PubMed ID: 25166608
[TBL] [Abstract][Full Text] [Related]
4. [Primary prevention of urologic tumors: prostate cancer].
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
Urologe A; 2011 Oct; 50(10):1271-2, 1274-5. PubMed ID: 21927877
[TBL] [Abstract][Full Text] [Related]
5. [Mistletoe extract for treatment of urological tumors].
Suttmann H; Saar M; Ohlmann CH; Stöckle M; Kamradt J
Urologe A; 2012 Dec; 51(12):1656-62. PubMed ID: 22996421
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle in urology: Cancer.
Emilio S; Luigi V; Riccardo B; Carlo G
Urologia; 2019 Aug; 86(3):105-114. PubMed ID: 31431169
[TBL] [Abstract][Full Text] [Related]
7. Diet and nutrition in urologic cancer.
Kamat AM; Lamm DL
W V Med J; 2000; 96(3):449-54. PubMed ID: 14619137
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention using dutasteride: the REDUCE trial.
Gomella LG
Curr Opin Urol; 2005 Jan; 15(1):29-32. PubMed ID: 15586026
[TBL] [Abstract][Full Text] [Related]
9. A review of phase III clinical trials of prostate cancer chemoprevention.
Thorpe JF; Jain S; Marczylo TH; Gescher AJ; Steward WP; Mellon JK
Ann R Coll Surg Engl; 2007 Apr; 89(3):207-11. PubMed ID: 17394699
[TBL] [Abstract][Full Text] [Related]
10. [Secondary and tertiary prevention of urological tumors].
Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
Urologe A; 2011 Oct; 50(10):1283-7. PubMed ID: 21947262
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic prevention studies of prostate cancer.
Djavan B; Zlotta A; Schulman C; Teillac P; Iversen P; Boccon Gibod L; Bartsch G; Marberger M
J Urol; 2004 Feb; 171(2 Pt 2):S10-3; discussion S13-4. PubMed ID: 14713746
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of prostate cancer.
Vemana G; Hamilton RJ; Andriole GL; Freedland SJ
Annu Rev Med; 2014; 65():111-23. PubMed ID: 24188663
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
14. The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.
Tindall DJ; Rittmaster RS
J Urol; 2008 Apr; 179(4):1235-42. PubMed ID: 18280514
[TBL] [Abstract][Full Text] [Related]
15. [Chemoprevention of prostate cancer].
Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
[TBL] [Abstract][Full Text] [Related]
16. Update on chemoprevention for prostate cancer.
Strope SA; Andriole GL
Curr Opin Urol; 2010 May; 20(3):194-7. PubMed ID: 20216317
[TBL] [Abstract][Full Text] [Related]
17. Urological cancers and lifestyle: Nudging patients toward healthy behaviors.
Parsons JK
Urol Oncol; 2019 Jun; 37(6):357-358. PubMed ID: 30930098
[TBL] [Abstract][Full Text] [Related]
18. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part II.
Moyad MA
Curr Urol Rep; 2020 Mar; 21(3):15. PubMed ID: 32185555
[TBL] [Abstract][Full Text] [Related]
19. Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.
Helfand BT; Blackwell RH; McVary KT
J Urol; 2010 Jul; 184(1):218-23. PubMed ID: 20483154
[TBL] [Abstract][Full Text] [Related]
20. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
